Vincent Rajkumar

I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives.

1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.

I’m at the @UpToDate Editors meeting today. I’ve been an author/section editor for 20 years. The breaking news is UpToDate Expert AI.

Check out UpToDate Expert AI at your institutions. You should have access if you have access to UpToDate.

UpToDate Expert AI is unique. It is AI plus the world’s top experts analysis and interpretation rolled into one. It offers AI’s magic and proficiency with the human expert element added.

In my experience AI is incredibly helpful but very few of us rely solely on AI to make clinical decisions for a serious illness. Patients still want input from the human expert. Thats what makes UpToDate Expert AI unique. It has both. That helps the treating physician make the best management choice for their patient.

Listening to @EZerhouni1 former Director of NIH this morning as VOA meeting.

The first slide! 100% truth. Unlike math and physics we are a 100 years away from understanding human biology. See thread for implications.

Just out ASH abstracts online: I will present overall survival results of AQUILA trial in high risk smoldering myeloma at #ASH26

Overall survival was significantly improved with Dara; significant 48% reduction in risk of death (HR 0.52; 95% CI, 0.32–0.87; P=0.0108). The 7-year OS rate was 87.8% with Dara versus 78.7% with observation. Learn more at the live meeting.
@thanosdimop @SagarLonialMD @PlasmaCellPete @mvmateos @ASH_hematology onlineprogram.hematology.org/paper-details.…

An effective Board of Directors can shape an organization. @montypal has the vision and leadership to guide and grow ASCO nationally and internationally.